Reviews in Medical Virology
Reviews in Medical Virology is a journal indexed in SJR in Infectious Diseases and Virology with an H index of 110. It has a price of 3083 €. It has an SJR impact factor of 2,091 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,091.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
2,091
H-index
110
Docs (year)
107
Docs 3y
315
Total refs
11209
Cites 3y
2398
Citable 3y
289
Cites/Doc 2y
7.6
Ref/Doc
104.76
Immediate OA
3083 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Diagnosis of congenital CMV infection via dried blood spots
View moreWhen prevalence of infection may not directly reflect the burden of disease
View moreHepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV)
View moreHantavirus infections in Europe and their impact on public health
View moreGeneration of influenza A virus from cloned cDNAs ? historical perspective and outlook for the new millenium
View moreFunctional association between viral and cellular transcription during influenza virus infection
View moreFrom restriction factors to restriction enzymes
View moreFacilitating viral recombination
View moreEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome
View moreEpidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer
View moreEbola in West Africa: the end of the first year
View moreDrug abuse, innate immunity and hepatitis C virus
View moreDoes SV40 infection contribute to the development of human cancers?
View moreAcquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?
View moreDevelopment of antiviral drugs for the treatment of hepatitis C at an accelerating pace
View moreDefinitions for warning signs and signs of severe dengue according to the WHO 2009 classification: Systematic review of literature
View moreDefining the boundaries of public health
View moreCurrent therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C
View moreClassic paper: Fenner on the exanthemata
View moreBoom and bust from influenza
View moreAntiviral developments
View moreAntiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8
View moreAnnexin A2 extracellular translocation and virus interaction: A potential target for antivirus-drug discovery
View moreAn earlier role for viral pharmacodynamics
View more